Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-032863

Chairman and CEO bought 2,700 shares at an average $1.37 ($3,689)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-05-27 Purchase +500 $1.35 $675 10,637,593 D
Niihara Yutaka Chairman and CEO 2020-05-28 Purchase +2,200 $1.37 $3,014 10,639,793 D
Open-market purchases · 2,700 sh · avg $1.37 · $3,689
Loading xslF345X03/doc4.xml…